https://brandessenceresearch.com/ Logo

Hereditary Testing Market

Hereditary Testing Market Size, Share & Trends Analysis Report

Hereditary Testing Market Size, Share, Statistics & Trends Analysis Report By Hereditary Cancer Testing (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Ovarian Cancer, Prostate Cancer, Stomach/Gastric Cancer, Melanoma, Sarcoma, Uterine Cancer, Pancreatic Cancer, Others), Hereditary Non-Cancer Testing (Genetic Tests, Newborn Genetic Screening, Preimplantation Genetic Diagnosis and Screening, Non-invasive Prenatal Testing (NIPT) and Carrier Screening Tests) Other Based On Region, And Segment Forecasts, 2024 – 2030

Published
Report ID : BMRC 3011
Number of pages : 300
Published Date : Aug 2024
Category : Medical Device
Delivery Timeline : 48 hrs

Key Players

  • CENTOGENE N.V. (Germany)
  • Ambry Genetics (U.S.)
  • Myriad Genetics, Inc. (U.S.)
  • NeoGenomics Laboratories (U.S.)
  • Quest Diagnostics Incorporated (U.S.)
  • PreventionGenetics (U.S.)
  • Fulgent Genetics (U.S.)
  • Invitae Corporation (U.S.)
  • Medical Diagnostic Laboratories, L.L.C. (U.S.)
  • Natera (U.S.)
  • Caris Life Sciences (U.S.)
  • LabSolutions (U.S.)
  • Progenity Inc. (U.S.)
  • ARUP Laboratories (U.S.)

Market Segmentation

Hereditary Cancer Testing

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Stomach/Gastric Cancer
  • Melanoma
  • Sarcoma
  • Uterine Cancer
  • Pancreatic Cancer
  • Others

Hereditary Non-Cancer Testing

  • Genetic Tests
  • Newborn Genetic Screening
  • Preimplantation Genetic Diagnosis and Screening
  • Non-invasive Prenatal Testing (NIPT
  • Carrier Screening Test
SUMMARY
VishalSawant
Vishal Sawant
Business Development
vishal@brandessenceresearch.com
+91 8830 254 358
Segmentation
Segments

Market Segmentation

Hereditary Cancer Testing

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Stomach/Gastric Cancer
  • Melanoma
  • Sarcoma
  • Uterine Cancer
  • Pancreatic Cancer
  • Others

Hereditary Non-Cancer Testing

  • Genetic Tests
  • Newborn Genetic Screening
  • Preimplantation Genetic Diagnosis and Screening
  • Non-invasive Prenatal Testing (NIPT
  • Carrier Screening Test
Country
Regions and Country

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of MEA
Company
Key Players

Key Players

  • CENTOGENE N.V. (Germany)
  • Ambry Genetics (U.S.)
  • Myriad Genetics, Inc. (U.S.)
  • NeoGenomics Laboratories (U.S.)
  • Quest Diagnostics Incorporated (U.S.)
  • PreventionGenetics (U.S.)
  • Fulgent Genetics (U.S.)
  • Invitae Corporation (U.S.)
  • Medical Diagnostic Laboratories, L.L.C. (U.S.)
  • Natera (U.S.)
  • Caris Life Sciences (U.S.)
  • LabSolutions (U.S.)
  • Progenity Inc. (U.S.)
  • ARUP Laboratories (U.S.)

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

BrandEssence® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®

PaymentModes